5, 2007 .

, 4

www.sia-r.ru

5, 4, 2007




..
:
..
..
:
..
..
..
:
..
..
..
..
..
( )
..
..
..
..
..
..
..
..
..
..
..
..
( )
..
..
..
..
..
..
:
.. ()
.. (-)
.. ()
.. ()
.. ()
.. (-)
.. (-)
.. ()
.. ()
.. (-)
.. (-)
.. ()
.. (-)
.. ()
.. ()
.. ()
.. ()
.. ()

:
, 127055, / 37
: +7 495 540 2983
E-mail:media@conmed.ru

. . : 77-13526

. ,
.
,
,
.
. 2007

,

.., .., .., ..,
.., C..

.., .., .., .., ..

10

.., .., ..

14

:
..

20

3-
,

..

25

.., ..

31

.
?
.., ..

40

1- ()


.., .., .., .., ..,
.., ..

44

-
.., .., ..

48

49

,

.., .., .., ..

50

55

, ,

65

66

2008 . .

,
1967 . . .. . ,
. ..,
, ,
.
.. .
, , , - , . ,
,
.
.. .
- , , ,
.
. 500 , 25 .

24

| 4 | 2007

.. , , , ,
.
.. .
.
..
. ,

.
.. . ..
. ..
, - .

, .
, .. . 70 180 . .
, , , ..
.
.. ,
. ,
, .
..
,
,
,
, .
2007 .
.. II .
.. , ,
, .
,
..
.
.

www.sia-r.ru

,

..1, ..2, ..1, ..1, ..1, C..1
1
,
2

,
,

:
,

.

, ,

.
, ,
,

.

,

,
:



.
, -

www.sia-r.ru

, , .
,
,
(
).


:


.

, .

.



.

, ,
, , .
:

( ) , .


,
.



,
:
1. .
2.
.
3.

. .
4. , .

-

| 4 | 2007

6
.
,

.

( ) ,

,

.
,
, , ,
,
.


.

:
( , ,
).
(
, , ).

( , ,
).

,
.
.

,
, , . -

| 4 | 2007

, .

.


.
..- ..
, .
1.

. , ,

.
2.


(
).
3.

, . , .
4. .

, , . , .

. ,
( )
( ).
5.
(.. )
, , .

6.

,
, ,
.

. , , ,
, .
,
,
34
, .

:
1.

, ,
:

,
.

, , 34

.

,
,
, .


; -

www.sia-r.ru


,
; .
,
,
( 1 ), ,
. . - : ,
,
.
812
, .
2. .
: ,
, (
, , ).
, , .


,
, .




, , ,
.

www.sia-r.ru

, ,
. ( , ) .
, , , , ,
, .

812 .
,

. 7-
, .

-
,

.

.
.


.

, ,

, .

, ..
.
-

7
,
,

.
,
,
, .
, ,
.


. ,
,
-
. (, ), (
25 . .

).

.

- , .

, .
,
.

8- . -

| 4 | 2007

8
.

.
.
.
,
, ,

( 10
, APACHE II 14
),
, .

.

.
,

- ,
.
,
(),
(
) .

,
.


. -

| 4 | 2007

,
.

- ,

,

.
,
,

, .

,
. ,
, .
,
,

(
,
).
(
87% ) .



15%, .



: , , -

, .


, , - (),
.

.
. ,

,
,



.
. ,

.
:
,
.
.
, .

, ,
.

www.sia-r.ru


,

30%.


,
.

;
. , ,

.


.

:

.
, :
( 5 )
, , ,
. ,
23
. ,
, ,

( :
,

), -

www.sia-r.ru

.


.

.


, .

, , ,
.

:
,
(
: , , ).
.

,
.
.


.

-

9
, .
, ,
, ,

.

1. - ,

(, ),
.

. 90% . + . ,
, ,
.
2.
, .
,
,
. ; .


.
3.

, ,
.
( ) .

.
4. ,

, -

| 4 | 2007

10
(

).

,
, .

, ,
. ,

.

.
, , -,
- (


).

, , .

-

, -.
- . , , , ,
. .

,
.

..1, ..2, ..3, ..4, ..3
1
. ..
2
,
3
,
4
,

,
.
, *.
,
,
() ,
(1224 ):
,
.,

12 ,
;
, ,
;
.

.
,
,


. -

. , , . ,
,
, .

,

, :
(/
/);

* .
/.
| 4 | 2007

www.sia-r.ru

 IIIII
(, , ) ;
(,
, , , ) .
, . () ( )
.
, /, /, / /, -
, E. coli.
- (),

.

, -

.

( ) /
, : + ; ; + ; .
, ,
:
( );
(>2 );
(
, , , );
;
;
;
.

12
;




,
.



:
(
);

(/);
IV
() .



.
:

;

III (, , , ) ;
/ /;

, , .
(, )
.
,
, -
.

.

| 4 | 2007

.
.


,

, , .
(
!)
.


. E. faecium
, .
,
,
Candida spp.
, ,
.
Candida albicans
. Candida (C.
crusei, C. glabrata)

(),
, ( ).
, Candida spp. ,
, .
(
), ().


.

.


.

,
,
.
,
: ( ), , .
, ,

, ,
.

, 4872
. . , ,


( ).

( 4872 )
:
;
( 38,9);
;

www.sia-r.ru

 .
. - 57
( , .) .
()
:
:
38 36,
90 /,
20 1 ,
12109/ 4109/

10%;
,
;
;
.
( ) .
( 37,9)


, (912109/) .

710 . -
,
.

,
.

14

.., .., ..

XIX

.

.

,
, .

.
1950-
. ,
,
,
, , [13].
,

, 1960- [4, 5].
1961 . [6]. ,



,
S.
aureus,

1.


I
I
II
( III)

, ,
,

,

1985 .
I
II
III

1999 .
I
I
II

,
, . I

. . I
1

, , . I
.
1
. 1

, . 1


. 1

. 1

| 4 | 2007

www.sia-r.ru


()

.
.

[711].
1964 .
-
.
,
,

(
30 ) [12].
1970-
,


(,
.). .
1980 1990- 100
,
[1317].
()

()

1985 . 1999 . (. 1) [18].

2003 .
.
2007 .
, - [19].


. -

:
, 2003 .
, .
, ,
,
.

?

, .

15

.
, . , ,
,
. .

,

.

16


:
,
,
,
.

, ,

.
,
.

.





.
, ,

, .

,
.
. 2

.

(. 3).

?
,

. . 2.
- (
, )

,
. ,
-

2.

, ,

,
,

. ,

.
( )
, , ,
,

( ,
)

Stafhylococcus aureus; coagulase-negative staphylococci
S. aureus; coagulase-negative staphylococci
S. aureus; coagulase-negative staphylococci
S. aureus; coagulase-negative staphylococci
S. aureus; coagulase-negative staphylococci, streptococci;
gram-negative bacilli
S. aureus; coagulase-negative staphylococci;
gram-negative bacilli
S. aureus; coagulase-negative staphylococci,
Streptococcus pneumoniae; gram-negative bacilli
S. aureus; coagulase-negative staphylococci
Gram-negative bacilli; anaerobes
Gram-negative bacilli; anaerobes
Gram-negative bacilli; anaerobes
Gram-negative bacilli; streptococci;
oropharyngeal anaerobes (peptostreptococci)
S. aureus; streptococci; oropharyngeal anaerobes
(peptostreptococci)
Gram-negative bacilli; enterococci; streptococci
,
Gram-negative bacilli

3.
. I. , ,
, - . . ( )
-. II. , ,
, ,

-. III. ,
- , ( ). .

. IV. ( ). , .
,

| 4 | 2007

www.sia-r.ru

17

4. [9]

1
1,5 / (750
8 16 )
2 / (1
8 16 )

1 .


,
2- .

1,5 / (750
8 16 )
2 / (1
8 16 )

1

,

1 .

-
,

/
/

1,2 / (1,2
8 16 )
3 / (1,5
6 12 )
1,5 / (750
8 16 ) +
0,5 / ( )
2 / (1
6 12 )
1,2 / (1,2
8 16 )
3 / (1,5
6 12 )
1,5 / (750
8 16 ) +
0,5 / ( )
2 / (1
6 12 )
1,5 / + 750
8 16
2 / +1
8 16
1,2 / (1,2
8 16 )
0,9 / + 0,6
6, 12 18
2 /
1,5 /
1,2 /
3 /
0,9 /
2 /
1,5 /

,
,

4
4

1,5 /
2 /
1 /
0,4 /

5,
,

3
4
4

1,5 /
2 /
0,9 /
1 /
0,4 /

/
/

/
+

/
/
+

(,
)

/
3

www.sia-r.ru

1,5 /
1 /

(
3 )
,
1 /
( )



2

24

2448
( 0,75 8 ,
1 8 ,
1 12 , 0,4
24 )
.


24
.
IV

1,5 /

. 1
1,2 /

3 /

2 /
1,2 / (1,2
8 12 )

| 4 | 2007

18
4.

I
II

1
3 / (1,5
6 12 )
1,5 / (0,75
8 16 )
2 / (1
8 16 )
2 / (1
6 12 )
1 /,
100
,
200

1,5 /
1,2 /
2 /
2 /

200 /
500
1,5 /
1,2 /
2 /

( ,
)

.
.

,

.
6
23
.

. 1 3060 . 3 .
2
, . : 1 + 1
1 ; + () + ().
3
- .
4
- - .
5
/ .
6
80 , , , .
/ ; ; ; /
/; / /.

(
,
).
,

,
.
:
1) , ;
2) : ( ), , ,
.

| 4 | 2007

.
, - ,

,
.

?

.
, , .

, -

.
, , .
,

-
.

(
II
),
;
,

.
.

www.sia-r.ru



,
.
.

, , - Staphylococcus aureus,
, - .

, .




. ,



, . ,
34 .
( )
:
,
, .
,


,
,
12 30

().
,

:

,
(
1 ).
1
.
,
.


. 4.

, Cochrane collaboration,

.
,
.
, .


Internet. Cochrane
collaboration
.
Cochrane collaboratioin 3, 2007 .,
30 . ,

[18].

1. Ehrenkranz NJ. Antimicrobial prophylaxis in surgery: mechanisms, misconceptions,

and mischief. Infect Control Hosp Epidemiol
1993; 14 (2): 99106.
2. Langley JM, LeBlanc JC, Drake J, Milner R.
Efficacy of antimicrobial prophylaxis in
placement of cerebrospinal fluid shunts:
meta-analysis. Clin Infect Dis 1993; 17:
98103.
3. McDonald M, Grabsch E, Marshall C,
Forbes A. Single- versus multiple-dose

19
antimicrobial prophylaxis for major
surgery: a systematic review. Aust NZJ Surg
1998; 68 38896.
4. Antimicrobial prophylaxis in surgery. Med
Lett Drugs Ther 1999; 41: 7580.
5. Aznar R, Mateu M, Miro JM et al. Antibiotic
prophylaxis in non-cardiac thoracic
surgery: cefazolin versus placebo. Eurj Cardiothorac Surg 1991; 5: 51S8.
6. Burke JF. The effective period of preventive antibiotic action in experimental incision and dermal lesions. Surgery 1961; 50:
1618.
7. Bartiett JG, Condon RE, Gorbach SL et al.
Veterans Administration Cooperative Study
on bowel preparation for elective colorectal
operation: impact of oral antibiotic regimen
on colonic flora, wound irrigation cultures
and bacteriology of septic complications.
Ann Surg 1978; 188: 24954.
8. Nichols RL, Holmes JW. Prophylaxis in
bowel surgery. Curr Clin Top Infect Dis
1995; 15: 7696.
9. Nichols RL. Antibiotic prophylaxis in
surgery. Chemother 1989; 1 (3): 1708.
10. Nichols RL. Surgical antibiotic prophylaxis. Med Clin North Am 1995; 79 (3):
50922.
11. Nichols RL, Webb WR, Jones JW et al. Efficacy of antibiotic prophylaxis in high risk
gastroduodenal operations. Am J Surg
1982; 143: 948.
12. Bernard HR, Cole WR. The prophylaxis of
surgical infection: the effect of prophylactic
antimicrobial drugs on the incidence of
infection following potentially contaminated operations. Surgery 1964; 56: 1519.
13. Centers for Disease Control and Prevention, National Center for Health Statistics
Vital and Health Statistics, Detailed diagnoses and procedures national hospital discharge survey 1994. Vol 127.Hyattsville
(MD): Department of Health and Human
Services; 1997.
14. Dellinger EP, Gross PA, Barrett TL et al.
Quality standard for antimicrobial prophylaxis in surgical procedures. Clin Infect Dis
1994; 18: 4227.
15. Guideline for prevention of Surgical site
infection. Infect Control Hosp Epidemiol
1999; 20 (4): 24779.
16. Hospital Infection Control Practices
Advisory Committee. Recommendations for
preventing the spread of vancomycin resistance. Infect Control Hasp Epidemiol 1995;
16 (2): 10513.
17. Nichols RL. Surgical infections: prevention and treatment 1965 to 1995. Am J
Surg 1996; 172: 6874.
18. Platt R. Guidelines for perioperative
antibiotic prophylaxis. In: Abrutyn E, Goldmann DA, Scheckler WE, eds. Sounders
Infection Control Reference Service.
Philadelphia: W.B. Sounders Co, 1997; p. 22
934.
19. The Cochrane Collaboration, a reprint
of a Cochrane protocol, prepared and
maintained by The Cochrane Collaboration
and published in The Cochrane Library
2007, Issue 3. http://www.thecochranelibrary.com

www.sia-r.ru

| 4 | 2007

20

:

..
- . .. , -
,
,

. (1995 .),

1 000 000 -
, . ,


(95 100 000 )
, . ,
,
. ,
,
,
,
,
. ,

.
,
, .
(1919 .),

.
3-
. 1960-
, ,

| 4 | 2007

2-
30- ( ).

, ;
5- .
, . ( 3 ) .
10 () 2-
().

, [1]. , ,
(
70%)
( 80%)

60 . , ,

.

: 1215, 5070 [2].
( 50%)
,
, .
C. tetani , ,
, .

. , .
,
1

15 .
,
, ,
,
,
.
, , ,
. C. tetani ,
,
,
.
, .
, . , (95%) -
,
.
. ,
,
C. tetani, - , .

(tetanus neonatorum). ,
( ).

www.sia-r.ru




,
[3, 4]. , C. tetani , .

(100 000 D) (50 000 Da)

, .

.
,
.
. ,

,
. , (-125,
-34),
[5], [3], .
,
. ,
,
,


. , . , .


[6]. - ,
-

www.sia-r.ru

21

. 1. (risus sardonicus).

,
. ,

,

.
,
.
.
, , ,
.
( )
, , , ().
- ()
.
, .
-
.

,

. , .

, , ,

. - , ,
, , , , .

,
, ,
, ,
.



(), (
), .

risus sardonicus (. 1).
(tetanus
descendes)
() , -

| 4 | 2007

22

. 2. :
();
();
();
().

(), ();
(. 2). ,

.
,
.
( ).

.

(120150

| 4 | 2007

/), (200220/120130 . .)
(1 . .).

,
.
.

,
,
,

, ( .).
,
, , ,
( , 5:1).
,
, :

, ,
,
, ,
;
,
;
,
,
;

( , ) ;

23 ;


;
.


. ,
, -

www.sia-r.ru

23

1.

II

III

910

IV

57

12

, . .
,
,
. ,
.

,

(. 1).


. 710 ,
(45 ) (23 ). , ,

.

(1820%) . , ,

( ,
),
C.
www.sia-r.ru

.
. .
.

. .
.
, .
;
30 1
, .
,
.
, .
, , ,
.
, (40
). -
(120 / ), .

-III

,

2.
.

( ),
, ,
. , ,
.
,
, ;
. ;
;

; ;

; ;
;
; ;

()

tetani. , ,
,
( )

,
.

,
..
(. 2).

:

;
, -

;

,
.



()
(30006000

).
(120 000 ).
1/2

( 1:10);
(45 ) ()
1/2 -

| 4 | 2007

24
. ,


.

,
;
.
.

, ,
. , , ,
C. tetani, . , ,
. ; , , [7].

.
,
.


.
,
.
, .

,
.


-

| 4 | 2007

. 10 /

[8].
, ,

, [9].


,
( .
), ( 250 ).

: 2,5% 2
, 1% 12 , 2% 2 , 0,05%
1 (23 ).

[10, 11].

-IV , ,

(). ,
, ,
, . .

. ( 8
/),

[12].
[13].
.
, - ( .)

- ,

[14].

,
[15].
, .

.

.
,
,
-
().
,
, . 2. ,



.


. ,
. ,

, . ,
, ,
, .

, , .
-I, II
,
III IV , . -

www.sia-r.ru


, ,
, .
.
, , . , - ,
.
,
40%.
,
,

.

,
[16, 17].

1. Weiss BP, Strassburg MA, Feeley JC. Tetanus

and diphtheria immunity in elderly population. Am J Pub Health 1983; 73: 8024.
2. Gergen PJ, McQuillan GM, Kiely M et al. A
population-based serologic survey of
immunity to tetanus in United States. N Engl
J Med 1995; 332: 7616.
3. .. . .: , 1966.
4. .. . .: ,
1971.
5. Erdmann G, Wiegand H, Wellhoner HH.
Intraaxonal and extraaxonal transport of
I125-tetanus toxin. Naunyn Schmiedebergs
Arch Pharmacol 1975; 290: 35773.
6. Collingridge GL, Davis J. The in vitro inhibition of GABA release by tetanus toxin.
Neurorharmacology 1982; 21: 8515.
7. Udvadia FE. Heamodynamis in severe in
tetanus. In: Udwadia F.E. ed., Tetanus. N.York: Oxford University Press, 1994.
8. Lipman J, James M, Erskine J et al. Autonomic dysfunction in severe tetanus: magnesium sulfate as an adjunct to deep sedation. Crit Care Med 1987; 15: 9878.

25
9. Gyasi HK, Fahr J, Kurian E, Mathew M.
Midazolam for prolonged intravenous
sedation in patients with tetanus. Mid E J
Anesth 1993; 12: 13541.
10. Borgeat A, Popovic V, Schvander D. Efficiency of a continuous infusion of propafol
in a patient with tetanus. Crit Care Med
1991; 19: 2957.
11. Peduto VA, Pisanu GM, Piga M. Midasolam, propafol and clonidine for sedation
and control of autonomic dysfunction in
severe generalized tetanus. Minerv Anesth
1993; 59: 1718.
12. Wright DK, Lalloo UG, Nayiger S, Govender P. Autonomic nervous system dysfunction in severe tetanus. Crit Care Med 1989;
17: 3715.
13. Rocke DA, Wesley AG, Pather M, Calver
AD. Morphine in tetanus the management
of sympathetic nervous system over activity.
S Afr Med J 1986; 70: 6668.
14. Einterz EM, Bates ME. Caring for neonatal tetanus: a review of 237 cases. J Trop
Paedatr 1991; 37: 17981.
15. Cook TM, Protheroe RT, Handel JM.
Tetanus: a review of the literature. Br J
Anaesth 2001; 87: 47787.
16. .. . . . 1969; 12:
326.
17. Ambache N, Lippold O. Bradycardia of
central origin produced by injections of
tetanus toxin. J Physiol 1949; 108: 18696.

3-

,


..
,

(), ,


.



()
[5, 6].

www.sia-r.ru

().
, ,
,
, -

, ,
.
,
, ,
[13, 6, 7].
, .

| 4 | 2007

26
-
,
,
(), [57].

:
1- .
,
,
.
2-
.

, , , .
(:
IL-1, IL-6, IL-8, TNF .), , IL-4, IL-10, IL-13, TNF ., .
- , , .
3- .

: TNF-, IL-1, IL-6, IL-10, TGF-,
INF- ( ),

,
, .
,
, , ,

, - . -

| 4 | 2007

, -, ,
.

-


.
, ,

, ,

.

; ,
.
,

. .
, , .

()
,

,
.

.
, -
.
TNF . -

, . , TNF [810].
()
.
, , [1115].


[6].

() ,

[11, 12].
, - ,
.


,

. [23]
-III (AT-III). -III
.
-III, .

www.sia-r.ru


4 ()



[1921].

()
, .
, ,
,

.



.

6,3%.
:

-II 25 13%; 75
15,6% [18].
, ,
,
.
, ,

.

TNF- . ,
7 -
(7nAChR).
7nAChR
NF-kB,

[33, 34].

www.sia-r.ru

,

()

.

10 [25].

3
(), , , . ,
3.
3-


(),
, , P-450.
(,
, )
().

, .
6- , 3-

.
,

: 3- , 6- .
.
3-
, 6 9-.
3- (, ),

27

. 3- (5,
5, 3) .


TNF IL-1 [26].
. 3-
IL-2, , ,
..
[27].
3-

TNF-
(VCAM-1) , [28].

3-. 3-
6-

.


().
Gianotti . ,
3-

IL-6
IL-2,
[24]. , (18,0/),
TNF IL-1

[26].
,

. TNF -

| 4 | 2007

28

, ,
[27].
, ,
,
[28].
12 ,

,
,

,
( 2,6 ) ( 2,9 )
[25].

3-:

3-

. 3-,

.

10%
(),
(20:5 3),
(22:6 3)
(18 3) 3-.

2.
, ,

| 4 | 2007

-
.
,
.
3 6-
,
.
,
TNF IL-1
3-
.
3- ,
,
, ,
[30].
3-
.
3-
: ,
, ,
, [29, 31,40].
3- .
, ,
[35].

5
350 / ( 3 100
150 6 ) 24
-

3- [30].
, 3-,
NF-kB
[36, 37].



(661
82 ).
(n=276)
SAPSII 7% (p=0,0027),

26% [32].
, Grecu [38].

, 0,10,2
//.


,
( )
3- .
36,1%,
-
47,2% [32].

E. Tsekos .

3- [39].
,
100 / 23
.
-

www.sia-r.ru

29

SAPS-II

SAPS-II

446
118
80
17
661

10,710,9
24,218,7
49,121,4
54,320,7
18,920,0

+0,1% (-3,03.0)
-9,8% (-17,02,6)
-34,1% (-43,225,0)
-42,6% (-60,824.4)
-7,4% (-10,44,4)

0,96
0,007
0,001
0,001
0,001

1-
2-
3-

(=0,02) 6% ( 3-),
15,5%, ,
3-
14%.


[41].
,

3- [42, 43].



()
.
.
,
,
.
. 6- , ,
. 3-, ,
.
,
3-
,
.

www.sia-r.ru

- , ,

,
23
(. ) [32].

(SAPSII=10,710,9), ,
. ,

, - .
. ,
0,050,2 //
.
. 89 .


1. 3-
()
.
2.

.
3.
, .

4. 3-

,

.
5.
0,10,2 //
6. .

C

,
,

.


, .
,

- . ,
,


().



.

| 4 | 2007

30
3-
()

. 23 SAPS-II 25
.

1. Bone R.C. Sir Isaac Newton, sepsis, SIRS,

and CARS. Crit. Care Med. 1996; 245:
11258.
2. Bone R.. Toward a theory regarding the
pathogenesis of the systemic inflammatory
response syndrome: what we do and do not
know about cytokine regulation. Critical
Care Medicine1996; 24: 16372.
3. Livingston D., Detch E. Multiple organ failure: a common problem in surgical intensive care unit patients. Ann. Med. 1995; 27:
1320.
4. ..
.. . 1995; 4:
815.
5. Beal A.L., Cerra F.B. Multiple organ failure
syndrome in the 1990s: Systemic inflammatory response and organ dysfunction.
JAMA 1999; 279: 22680.
6. Deitch E.A., Vincent J.-l.., Windsor A. Sepsis
and multiple organ dysfunction: a multidisciplinary approach. W.B.Saunders; 2002.
7. .., ..
.
2002; .1(2): 1722.
8. Gerlach H., Gerlach M., Kermer T. et al.
Ischemia/hypoxia- induced cell damage
mediated by induced receptor-ligand interaction of TNF. Intensive Care Med
1994(S1); 20: A243
9. Wrenger K., Marlion B., Baier J .Differences
in arterial and venous TNF activity in vivo
upon in vitro stimulation during sepsis.
Intensive Care Med 1994(S1); 20: A256
10. Arya G., Garcia V. effects of in vivo
hypoxia/ reoxygenation on cytokine elaboration in septic animals. Intensive Care Med
1994(S1); 20: A278
11. Chanand J., Ayala A., Chaudry H. Influence of hydroxyethystarch on inflammatory
cytokine release following trauma and
hemorrhagic shock. Intensive Care Med
1994(S1); 20: A325
12. Boldt J., Muller M., Heensen M. Influence
of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients. Crit
Care Med 1996; 24: 385391

13. Dietrich H., Nohe B., Rothmund M. Influence different colloids on the expression of
endothelial cell adhesion molecules. Chock
1997;7:A197
14. Chu U., Huffman S., Clevenger F. effects of
hypertonic saline on lung TNF and neutrophil activation in hemorrhahed, head
injured rats. Chock 1997;7:A220
15. Moor F., Moor E., Sauia a. Blood transfusion: an independent risk factor for postinjury multiple organ failure. Arch Surg 1997;
132:620625
16. Unsaro A., Russel J. Could anti-inflammatory action of catecholamines explain
the possible effect of supranormal oxygen
delivery in critically ill surgical patients.
Intensive Care Med 2000;26:299-304.
17. Annane D.,Sebille V., Charpentier C. et al.
. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality
in patients with septic shock. JAMA
2002;288:862871.
18. Bernard G.,Vincent J.L.,Laterre P.F. et
al.The recombinant human activated protein C worldwide evaluation in severe sepsis(PROWESS)study group. Efficacy and
safety of recombinant human activated
protein C for severe sepsis . N Engl J Med
2001; 344: 699709.
19. Fourrier F.,Chopin C.,Huart J.J. et al. Double-blind, placebo-controlled trial of
antithrombin III concentrates in septic
shock with disseminated intravascular
coagulation. Chest 1993; 104: 8828.
20. Warren B.,Eid A.,Singer P. et al. High
dose antithrombine III in severe sepsis..A
randomized controlled trial. JAMA 2001;
286: 186978.
21. Eisel B.,Lamy M.,Thijs L. et al. Antithrombine III in patients with severe sepsis. Intensive Care Med 1998; 24: 66372.
22. Briegel J., Kellermann W., Forst et al. Lowdose hydrocortisone infusion attenuates the
systemic inflammatory response syndrome.
Clin.Invest 1994; 72: 7827.
23. Nelson H., Alexander J., MaoJ. The effects
of pentoxifylline on survival and intestinal
cytokine mRNA transcription in a rat model
of ongoing peritoneal sepsis. Crit Care Med
1999; 27: 1139
24. Gianotti L., Braga M., Fortis Soldini L. Et
al. A prospective, randomized clinical trial
on perooperative feeding with an arginin,
omega-3 fatty acid-, an RNA-enriched
enteral diet: effect on host responce and
nutritional status. JPEN 1999; 23: 31420.
25. Beale RJ., Bryg DJ, Bihari DJ Immunonutrition in the critically ill: a systematic
review of clinical outcome. Crit Care Med
1999; 27: 2799805.
26. Enders S., Ghorbani R., Kelley V. et al. The
effect of dietary supplementation of IL-1
and tumor necrosis factor by mononuclear
cell. N Engl J Med 1989; 320: 26571.
27. Grimble RF, Howell WM., O'Relly G. et al.
The ability fish oil to suppress TNF- production by peripheral blood mononuclear
cell in healthy men is associated with poly-

morphisms in genes with influence TNF-

production. AJCN 2002; 76: 4549.
28. Aiko S., Yoshizumi Y., Tsuwano S. et al. The
effect of immediate enteral feeding with a
formula containing high levels of -3 fatty
acids in patients after surgery for
esophageal cancer. JPEN 2005; 29: 1417.
29. Calder PC n-3 fatty acid, inflammation
and immunity-relevance to postsurgical
and critically ill patients. Lipids 2004; 39:
114761.
30. Mayer K., Gokorsch S., Fegbeutel C. et al.
Parenteral nutrition with fish oil modulate
cytokine response in patients with sepsis. Am
R Respir Crit Care Med 2003; 167:
132128.
31. Calder PC Use fish oil in parenteral
nutrition: rational and reality. Proc Nutr Soc
2006; 65: 26477.
32. Heller AR , Rossler S, Litz RJ et al. -3 fatty
acids improve diagnose-related clinical
outcome. Crit Care Med 2006; 34: 9729.
33. Borovikova I.V., Ivanova S., Zhang M. Et al.
Vagus nerve stimulation attenuates the systemic inflammatory responce to endotoxin.
Nature 2000; 405: 4518.
34. Pavlov V.A., Ochani M., Yang L. et al. Selective 7-nicotinic acetylcholine receptor
agonist GTS 21 improves survival in
murine endotoxemia and severe sepsis. Crit
Care Med 2007; 35(4): 113944.
35. Pluess T., Hayoz D., Berger M. Intravenous fish oil the physiological response to
endotoxin in healthy subjects. Intensive
Care Med 2007; 33: 78997.
36. Lee JV, Plakidas A., Lee WH et al. Differential modulation of Toll-like receptors by
fatty acide. J Lip Res 2003; 44: 47986.
37. Pseidel E., Schywalsky M., Tschaikowsky
K. et al. Fish-oil supplemented parenteral
diets normalize splanchnic blood flow and
improve killing of translocated bacteria. Crit
Care Med 2000; 28: 148996.
38. Grecu I., Mirea L., Grintesku I. Parenteral
fish oil supplementation in patients with
abdominal sepsis. Abstr. Clin Nutr 2003;
22(Suppl): 23.
39. Tsekos E., Reuter C., Stehle P. et al. Perioperative aministration of parenteral fish oil
supplemets in a routine clinical setting
improves patient outcome after major
abdominal surgery. Clinical Nutrition 2004;
23(3): 32530.
40. Koch T., Heller A. Benefits of -3 fatty
acids in parenteral nutrition. Clinical Nutrition Supplements 2005 vol.1 (3): 1724.
41. Weiss G. Immunomodulation by perioperative administration of n-3 PUFA. Br J
Nutr 2002; 87(Suppl 1): 89.
42. Fearon KCH. The anticancer and anticachectic effects of n-3 fatty acids . Clin Nutr
2002; 21(supl2): 6973.
43. Heller AR, Rossel T, Gottshlich B. et al.
Omega-3 fatty acids improve liver and pancreas function in postoperative cancer
patients. Int J cancer 2004; 111: 6116.

| 4 | 2007

www.sia-r.ru

31

.., ..
,

-

,
[16].
,
0,51% [1, 3, 7],
,
68 ,
, 8% [1, 3, 5].
,
,
. , ()
,
, . ,
[1, 4, 8].
(1440%), , , , -

www.sia-r.ru

. 1. .

, , ,
, [1, 3, 9]. ,
[1, 10]. c

,
(
, ), , [3, 5, 11].

, , , , , [1, 3, 11, 12].
.. [8],
-

,
,

,
, - ,

. ,

, , , [1, 5].

() -
[1, 5, 12],

| 4 | 2007

32
. 2. -7-22.

. 3. .

, [13, 14].
()
[1, 13, 14]. ()
-

()
(0,5
),
,
, ,
. -


3540% [2, 4],
70 80% [1, 7, 15].


,

(),
,

[1, 5, 16, 17].

, . , [1, 5, 18].

- . -

| 4 | 2007

, , ,

(

4 . ) 1997
2007 .
494 : 457
(92,5%) , 22 (4,4%), - 15 (3,1%).
16 72
. 265 (53,6%),
229 (46,4%).
:
(),

.

www.sia-r.ru




, ,
(. 1).

.


.
.
,
.
(
54% ), 91,5%
8,5% ,
, .
(11,4%)
(24,9%), .
-
.
- -7-22 (. 2).
, , ,

(),
(, ),
, , .
18 (3,9%) , . 494
, . .
-

www.sia-r.ru

33

. 4. .

. 5. .

() 110-
,
.
:
1) ;
2) ;
3) .
:
1)
;
2) ;
3) ;
4) .

:
1) - -;
2)
104 1 .
,
,
3040%. 50%

, , .
, -

| 4 | 2007

34

. 6. .

. 7. .

(
) (
) 2

N-
0,710,74 / .
, ,
,
.

, , .
,
(, .).
3/05/0.

.

, (
).

. 8. () .

| 4 | 2007

-
457
(92,5%) .
398
(87,1%)
1 16
(), 59 (12,9%)
- . 67,4%
.
:
(, , , -) 139 (30,4%) ,
35 (7,7%), 98

www.sia-r.ru


(21,5%), (
) 82 (17,9%),
32 (7,1%), - 14 (3,1%), 11 (2,4%),

18 (3,9%),
11 (2,4%), 9 (1,9%)

8 (1,7%).

0,5 100 2.
, 1000 2.

() () 0,5 2
(
) , , ;
1,5 2.
.

(. 3) 92 (20,1%)

, . ,
,
.
(. 4)
72 (15,8%) .




(,
), , ,
.
. (. 5) 42
(9,2%)

, , .
(. 6)

www.sia-r.ru

35

. 9. .

. 10. .

, , 48 (10,5%)

() ,
.
4 (0,9%)


.
-
8 (1,7%) (
) I , II

V . ,


- (-).
. VY 9
(1,9%)

. (
1,0 2).

| 4 | 2007

36

. 11. .

. 12. :
.

42 (9,2%) . 10,70,6
.
79
(17,3%)
.

,
- .
.

,
(29 6,3%). (. 7)
,
.

,
, 17 (3,7%) .

| 4 | 2007

15 (3,3%)

,
.

2002 2007 . 22
-
: 6
(27,3%) 16
(72,3%) .

16 (72,7%) . I
9 (40,9%), II 6
(27,2%), III 4 (18,8%), IV
1 (4,4%) V 2
(9,1%) .
I 22

(), 1 ,
16 (72,7%)
. 22

316- I .

.
, , 1,52
.

www.sia-r.ru



. - .
.

6 (27,3%) .
16 (72,7%)

:

7 (31,8%)


(. 8) 9
(40,9%). ,
,
3 III
.

-
2001 2007 . - 15

-
()
(,
, ).

10 (66,6%) . I
6 (40%) , II 4 (26,6%), III 2
(13,3%), IV 1 (6,6%) V
2 (13,3%) .
15 .
9 (60%) , 6 (40%).
12 (80%)
.
-
516-
() .
I. , (. 9, 10).
II. (. 11).
III. (. 12).
I , II ( 1821 )

www.sia-r.ru

37

. 13. .

. 14. - .

, III ( 714
) II
, .
,
-
. ,
.

,
-

434 (94,9%)
. 23
(5%) . 6 (1,3%) . 10
(2,2%)
. , , 7 (1,5%) : 4
(0,9%) 3 (0,6%)
.
15
(3,3%) .
.

| 4 | 2007

38
16 ,
23 .
(
24,74,6 ),
.
( 69 5 ) 96,5%
. 7
(1,5%)

,
.
-
, (),

. 22


.
,
.



2 (9,1%)
.
15 -
.
(. 13).
,
.
(. 14).

- -

| 4 | 2007

2 , .

.
,
,
, .


, . 494
1 5
. ,
.
488
(98,7%)


. 4 (0,8%) , 1 (0,2%)
1 (0,2%)


,

, . ,
-


.
3 (0,7%) -
.
-
.
,

.

-

, 478
(96,7%) .

, ,
,
- .

,
(),
,


[1, 5, 10, 13, 19]. ,
, , -

.

.
,
( , , .)

,

[2,
10, 18, 2024],
, -
.
[9,
16]. ,
,
-
, ,

www.sia-r.ru



. ,


, , [23], , ,
, ,
, .

,
.

,
.
,

[1, 2, 5,
6, 13, 18, 21, 24].

,

.

,
, .

1.

.
2. 96,7%
.
3. ,
, ,
,

.

(). -

, .
4.
,

, , .

1. ..

. . ... - . . ., 2003.
2. .. . . 3. , 1996.
3. .. -
. .:
, 2002.
4. .., ..
. .:
, 1986.
5. .., .., ..
, - . .: -, 2005.

39
6. Gunther SF. Infections of the hand. Introduction and overview. Instr Course Lect
1990; 39: 52731.
7. Iselin M. ( .) . .
. , 1931.
8. .., .., .. . . .
... .: .
, 2004.
9. Martin Paul. Wound healing aiming for
perfect skin regeneration. .Martin. Sience
1997; 276 (5309): 7581.
10. Berger RA. Hand surgery. 2004; 1, 2:
1886.
11. Heierli P, Egloff DV. Infections de la main
epidemiologie. Ther Umsch Revue 1985;
42 (4): 2427.
12. Cantero I. Infections of the hand principles of general surgical technic. Ther
Umsch 1985; 42 (46): 2749.
13. .., ..,
.., .. .
. 2007; 10: 235.
14. Freeland AE. Hand fractures. (Repair,
Reconstruction and Rehabilitation). Edinburgh, Churchill Livingston, 2000.
15. Mark G. Infection of the hand: a specific
disease picture. Ther Umsch 1990; 47 (7):
58692.
16. Barbieri RA, Freeland AE. Osteomyelitis.
Hand Clin 1998; 14: 589.
17. Bieber EJ, Wood MB. Bone reconstruction. Clin Plast Surgery 1986; 13 (4):
64555.
18. .., ..
.
(
)
. . . .
... 2004; 2: 828.
19. Freeland AE. Hand fractures. (Repair,
Reconstruction and Rehabilitation). Edinburgh: Churchill Livingston, 2000.
20. .. , . .: , 1998.
21. .., .. . : i i,
1994.
22. Green DP, Hotchkiss R, Pederson WC.
Green's Operative hand surgery. 4th edition,
Edinburgh. Churchill Livingston. 1998; 2:
1856 p.
23. .., ..,
.., ..
. . 1990; 12:
859.
24. ..
: ( - ). . . ... - . . .,
1964.
25. ..


. . ... . . .
, 2001.
26. Hentz VR, Chase RA. Hand Surgery. (A
Clinical Atlas). W.B.Saunders, 2001.

www.sia-r.ru

| 4 | 2007

40

.

?
.., ..

;
9,

,

, .

,
. .

.


: (102
) (48 ), 9 1997 .
2005 . 7 .
. ,


.
.

,


.

| 4 | 2007

: , , - ,
, .

.


.

,

[13]. , ,

.
, ,
-.
, 8 4,6%,
,
(), 20,2 10,6%.


,
, . , ,

812 /, 2-
2030 //
0,130,26 //
200260 /.
, , .
,

[46],
.

- () [7]
.
. ,

,
.


.

(102
) (48 ) 1997 .
2005 .
7

www.sia-r.ru


.
.

:
6 14 ,

48 ,
15% 5%
.
,
. (),
, 30 . .
1
15 ,

9 . 1- , , ( ,

,
).

.

5,50,6
,

33,92,0%
(1078) ,
(.Frank, 1960) 58,82,5
(30125) .
29 .
, 3060 . 60 . .
, ,
17,22,1 (166),
7,40,7 (119), 10,10,8 (223). 102
28
( 27,4%), 6- 10 , 7-
11.
20 (19,6%) , 34 (33,3%)

www.sia-r.ru

. , L.Doughty
. [8], 4,20,1 (27).

9,90,7 (1,215 )
. ; 10,93,1 (148).
48 20 (41,6%)
, 28
(58,4%) .



6,40,8
(48) . 15 .

4 6-
3 7- .
16 ( 33,3%).
() 13,61,4
(630), 19,02,1
(943).
3,70,1 (25) L.Doughty.


[9,
10],
(

,

, ,
,
, )
35- .
, , ,

( ,
, - ).

41
[11, 12].
R.Bone
.

( )
,
7:00,
3,95,6
/.
("Sigma
chemical company", ). "Cormay multi" ().

(. 1).
, ,
2 , .
,

3- 5- ,
.
, ,

4-
: ,
3- , , ,

,
.
, [1315] .

,


1- (r=-42), 3-
(r=0,53),
4-

| 4 | 2007

42

1.

(n=74)
(n=28)
(n=34)
(n=20)

Mm

t
Mm

Mm

t
Mm

,
1-

2-

3-

4-

5-

6-

7-

7,70,5
2,816,8
1,0
8,30,4
3,115,6
7,00,6
3,012,0
1,0
8,30,8
2,816,8

7,60,7
3,020,1
2,0*
5,80,6
2,512,4
8,71,2
3,520,1
1,4
6,70,8
3,019,5

4,50,2
2,38,9
2,4*
6,91,0
3,018,7
4,50,4
2,38,9
0,25
4,40,2
2,87,0

4,60,2
2,38,9
1,6
5,40,5
2,09,4
4,00,2
2,35,2
3,5*
5,10,3
3,38,9

5,00,3
2,512,4
2,57*
6,80,7
4,012,5
5,20,4
2,78,5
0,6
4,80,5
2,512,4

4,30,2
1,99,2
0,9
5,21,0
1,18,9
4,40,4
1,99,2
0,6
4,20,2
2,66,9

3,90,1
1,87,3
1,8
5,50,8
4,17,8
3,8+0,2
1,86,7
1,5
4,1+0,2
2,17,3

. . 2: . * , p<0,05.

2.

(n=32)
(n=16)

(n=28)
(n=20)

Mm

t
Mm

Mm

t
Mm

, 2-

(r=-0,38).
(. 2). , 1-
2-
, 3- 5-

. -,
.
,
, . ,
, ,
,
[1618],
, , .
:

-

| 4 | 2007

,
1-

2-

3-

4-

5-

6-

7-

6,80,5
4,215,4
1,6
8,00,8
4,514,8
7,00,6
4,515,4
0,14
6,90,4
4,211,3

6,80,8
3,215,7
2,0
7,90,8
5,412,8
6,60,6
3,215,7
1,4
7,50,6
3,812,8

5,40,2
3,27,1
2,1*
7,30,6
4,014,0
6,10,5
3,214,0
0,2
5,90,3
4,09,8

5,00,3
3,37,9
0,9
5,60,6
2,810,9
5,00,4
2,810,9
1,25
5,50,3
3,38,7

4,50,2
2,65,6
5,6*
7,00,4
4,99,1
5,10,3
2,69,1
0,47
5,30,3
3,98,4

4,50,2
2,86,5
0,5
4,10,8
1,68,6
5,20,2
3,78,6
10,0*
3,20,2
1,65,2

4,00,5
1,410,7
1,4
5,00,5
3,18,1
4,60,2
2,810,7
2,8*
3,80,2
1,45,9

[19]?



5 . ,
48 . 3-
5-
.

, ,
. - 100% ( ), 5- 7- ,
.

, 48
,

(r=0,68 r=0,69 ). 3- (r=0,81 r=0,65 ),

(r=0,41),
5-
(r=0,76).

1.

,
,
.
.
2.

, ,



4- .
3.
, -

www.sia-r.ru


35-

.
4. ,

, ,

.

1. Van den Berghe G, Wouters P, Weekers F.

Intensive insulin therapy in critically ill
patients. N Engl J Med 2001; 345: 135967.
2. Lannoo E, de Deyne C, Colardyn F et al.
Personality change following head injury:
assessment with the NEO Five-Factor Inventory. Rehabilitation of Persons with Traumatic Brain Injury. CBM 1998; 1: 2000.
3. .., ..

. , 1995.
4. Taylor SI. Lilly Lecture: molecular mechanisms of insulin resistance. Lessons from
patients with mutations in the insulin-receptor gene. Diabetes 1992; 41: 147390.

5. Standards of Medical Care for Patients

With Diabetes Mellitus Diabetes Care. American Diabetes Association: Clinical Practice
Recommendations,
2001.
Copyright:
Medicus Amicus, 2002; 24 (suppl. 1).
6. .., ..,
.. . - .
Copyright: Medicus Amicus, 2002.
7. .., ..,
.. -
.
. , 2005.
8. .., .., ..
. - .. , 2003.
9. .., .., .. .
-
.


- .
, 2003; . 524.
10. .., ..,
.. . .

. , 1999; .
94108.

43
11. .., ..
- .
V
. ., 78 2005; . 556.
12. .., ..
. . . .
2004; . 2423.
13. .. . : . .: ,
2001.
14. . . .: ,
1993.
15. .. . . .: , 1997.
16. . . 2- . .
.., ... .: , 2005.
17. .
. .. .: .
, 2005.
18. ..
. ., 2005.
19. Lam AM, Winn HR, Cullen BF et al.
Hyperglycemia and neurological outcome
in patients with head injury. J Neurosurg
1991; 75: 54551.

www.sia-r.ru

| 4 | 2007

44

1-
()



.., .., .., .., .., ..,
..
. ..

,
.
1-
1s- 1r-
XII, XIa,
.

1- (,
)
, () () E. coli 055:B5
("Difco Lab.", USA). E.
coli 15 /
72 100% (n=10).
(n=78) 72 , -

. 1.
1- () 200
E. coli 055:B5 (15 /).

200 , 85% (p<0,0001).

48 (4872) , 13
(313) (p<0,05). 5-
- ( , - , , -6).
1- ()


, ,

.
: 1-
, , .

p<0,0001

| 4 | 2007

.


.
, .


-

www.sia-r.ru


,
[1, 2].

-
,
, . ,



[3]. 1- .
1-
1s-
1r-
,
XIIa, , .
1- (, . ..
, ), , .

, -
() , 12 24 , 2, 3, 5, 7, 11 13- ,
. -6 (-6) - (-).

"Quantikine mouse TNF-" "Quantikine mouse IL-6" ("R&D systems",

)
"Bio-Rad 680".
13 [4].

:

;

, ;
,
.

( , ).
, .
. -

45


p<0,05. ("GraphPad Prism
3.0"; "GraphPad Software", San
Diego, CA).

.
1-


E. coli 15
/ 72
100%
(n=10). (n=78) 72
12 . ,
72 85% (p<0,0001).

48 (4872) ,
13 (313; p<0,05) , (. 1).

.
24

(p<0,05) (. 2).
72
(p<0,05). 5- -

68- 57BL/6J
1820 ,
.
E.
coli 055:B5 ("Difco Lab.", ). E.
coli, 100%
(100),
15 /.
1-
(, , ) 200
0,2

E. coli. E. coli
(. 1).

www.sia-r.ru

. 2. -6
5 .
-6 48
.
/

| 4 | 2007

46
1.

1- ()
2- ()

1-
()

10
78

15 /
15 /

200 /

2.
1 3

/


12
24

12
24
2
3
5
7
11
3

, /100

7210*

72107270

0,7*

0,60,7

2000*
2000*

18003500
18902160

0,2*
0,2*

0,20,5
0,10,25

2010*
2140*
2900*
5600*
10250**
9050**
7500
8100

19902040
20402190
28502990
55005700
1020010500
88009200
73007800
78008200

0,3*
0,3*
0,4*
1,1**
1,7**
1,2**
1,0**
1,3**

0,20,4
0,20,3
0,30,4
0,91,3
1,71,9
1,11,3
1,01,2
0,81,5

. *p<0,05 ( , ), **p<0,005 ( , ).

10,2 .
1 3 (10,210,5 . 1 3),
11- 7,5 .
1 3 (7,37,8 . 1 3).
- . 48
, ,
(p<0,05). 3-

,
(. 2).
-6. 48 6 (p<0,0005). 3- 10 / (. 2).
-6 2- -

. 3. -
5 .
- 48
.
/

| 4 | 2007

(p<0,005).
-.
-
, -6.
24
2-

(p<0,0005; . 3). 72
- . -
2-
, .

1- . ,

,
1-
. 1- ,
[5].

www.sia-r.ru



1- [6].
1-

[7].



1-
. 1- (; , )
.
,
1 (), . ,
.
, , ,
[8].
, 1- , ,
500 / E. coli 9 200 /,
510- -

1- XII
,
4b/c
,
. ,

, -, -10,
-6 -8 [9].
, ,
: [10], , XII [11], , , [2],
[12].
,
1-
,
.

1. de Boer JP, Wolbink G-J, Thijs LG et al.

Interplay of complement and cytokines in
the pathogenesis of septic shock.
Immunopharmacology 1992; 24: 13548.
2. Liu D, Cai S,Gu J et al. C1 inhibitor prevents endotoxin shock via a direct interaction with lipopolysaccharide. J Immunol
2003; 171: 2594601.

47
3. Kirschfink M. C1-inhibitor: an antiinflammatory reagent with therapeutic
potential. Expert Opin Pharmacother 2001;
2 (7): 107383.
4.
()
. .
.., .., .. . .: , 2000.
5. Caliezi C, Wuillemin WA, Zeerleder S et al.
C1-esterase inhibitor: An anti-inflammatory
agent and its potential use in the treatment of
diseases other than hereditary angioedema.
Pharmacol Rev 2000; 52: 91112.
6. Nuijens JH, Eerenberg-Belmer AJM, Huijbregts CC et al. Proteolytic inactivation of
plasma C1 inhibitor in sepsis. J Clin Invest
1989; 84: 44350.
7. Hack CE, Ogilvie AC, Eisele B et al. C1
inhibitor substitution therapy in septic
shock and in vascular leak syndrome
induced by high doses of interleukin-2.
Intensive Care Med 1993; 19: 1928.
8. Rodriguez-Gaspar M, Santolaria F, Jarque-Lopez A et al. Prognostic value of
cytokines in SIRS general medical patients.
Cytokine 2001; 15 (4): 2326.
9. Jansen P, Eisele B, de Jong I, Changet A.
Effect of C1-inhibitor on inflammatory and
physiologic response patterns in primates
suffering from lethal septic shock. J Immunol
1998; 160: 47584.
10. Czermak B, Sarma C, Pierson R et al.
Protective effects of C5a blockage in sepsis.
Nat Med, 1999; 5: 788.
11. Colman R. Biologic activities of the contact
factors in vivo:potentiation of hypotension,
inflammation, fibrinolysis and inhibition of
cell adhesion, angiogenesis and thrombosis.
Thromb Haemostasis 1999; 82: 1568.
12. Cai S, Davis III AE. Complement regulatory protein C1 inhibitor binds to selectins
and interferes with endothelial-leukocyte
adhesion. J Immunol 2003; 171: 478691.
13. Stevens JH, O'Hanley P, Shapiro JM et al.
Effects of anti-C5a antibodies on the adult
respiratory distress syndrome in septic primates. J Clin Invest 1986; 77: 181826.
14. .., .. .
. .: , 1995.
15. .. .
. ,
. :
, 1983.

www.sia-r.ru

| 4 | 2007

48

.., .., ..
. ..,

-
.


,
.

,
.
-
405
. 75%
( 42% , 22%,
20%,
10%, 6%),
21% 4%
. -

IIIIV
- .
37%
: , , .


.

(, ),
, , ,
. , - ,
.
70%
.
Enterococcus faecalis, Streptococcus
viridans, intermedius, Staphyilococcus epidermidis. -

(-), ,
.
, , , -.
15% . , , (). ,

, .
0,5%.
, .
,


.

| 4 | 2007

www.sia-r.ru

49

.
, (3060% ,
)

.
, .
:

- ,

,
.

,

.
c "FlexiSeal Fecal Management System"
(ConvaTec A Bristol-Myers Squibb
Company)
, . -

, (. )
,
45 ,


.

:
( 3 )

;



.
"Flexi-Seal FMS":

50

"Flexi-Seal FMS"

,
;
;

;
;

(
).

, 29


.
. (II ) c

.

,
.

,

..1, ..1, ..1, ..2
, 2 ,

() , , .
.

2 [1].
,
.

| 4 | 2007

, , 23- , ,
, ,
,

.
,
, ,
, , -

,
[2].
, , , 30%, , 300% [3, 4].
, [4].
P. Ceriana . [5], 72

56 (78%) , 2 -

www.sia-r.ru

51

. 1. Multiflex.
1

1 , 2 , 3 ,
4 , 5 .

3 .

- . 35% [1].
[4, 68].
,


, , , [8]. ,
, [8].




(
, )

[8].
[4].

[1, 7].
, ,

www.sia-r.ru

. 2. Multiflex, .

,

.
,

.

2007 2007 .
4
,
, () TPS (TracheostomaPlatzhalter-Set) Multiflex ("Rsch",
).

.
, ,
(. 1).

.


,
. 4070, .
, .


("Rsch", ).


,

, .

, . ,

| 4 | 2007

52

.

. , , 3

. -

. ,
.
,

. ,

,
, .
Multiflex
525-
. 3
8 , 1 6 .
Multiflex, ,

(. 3).
, .


, ,
.

, -

. 3. ( .).
, , Multiflex,
.

. ,
,

(. 2).
T
,
,
, , , ( 6 ) , .

4 ,
.

3 -

( 2 , , 1
). 1
,
,
(.
).

2 , 2
.
8 .
2 1 , 5
7 .

81

82

17

23

,
, ,
P. aeruginosa
, P. aeruginosa,
Enterococcus spp.
- ,
- , ,
, ,
Acinetobacter baumanii
,
, ,
Pneumocystis carinii,

| 4 | 2007

15

55

34

122

www.sia-r.ru


,
. , .
, , . .


. , ,
, , ,
.

,
.


. , .

.

15 4 (.
). 3

. 1 ,
,

, . 2
. ., 82 ,
5 .
. , . , ,
( BiPAP Vision "Respironics Inc", ).
.
. ., -

www.sia-r.ru

, ,

. 4
, ,

. ,
(. ).

, .
, ,
.. [5]. ,
,

(, , ,
, , ) [5]. , , . , , ,
, .
,

(,
, ),

. 2 ,
.
/
-

53
, 70
, ,

[2]. ,
3 4 , .
. 53%
70

[9].
13% [9].
2 80
, , ,
.

. J.Bach L.Saporito ,

. ,

[1].

8590% ,

. 3601000
/ [1].
100%
,

160 /. 160 /

50% ,
160 /
[1].
.Ceriana
.,

[5].

[5]:
( , , );
2<60 . .;

;

,
,
..
30%;

| 4 | 2007

54
;

40 . .;
;
, .
[5].


, ,
,
, . 2 60
. . ,
, ,
. , ,
,

.
-.

-

- . - ,

.

, , ,
.
T . ,

.

(. . 2, 3),
.
, ,

, . ,
T, T.
, T
, . , .
T .
1

,

.
,
T
.
"KOKEN CO., LTD" ().
,
,
,
,

.

1. Bach JR, Saporito LR. Criteria for Extubation and Tracheostomy tube Removal for
Patients with Ventilatory failure. Chest
1996; 110: 156671.
2. Rothaar RC, Epstein SK. Extubation failure: magnitude of the problem, impact on
outcomes, and prevention. Current Opinion
in Critical Care 2003; 9: 5966.
3. Chadda K, Louis B, Benassa L et al. Physiological effects of decannulation in tracheostomized patients. Intensive Care Med
2002; 28: 17617.
4. Sasaki CT, Fukuda H, Kirchner JA. Laryngeal abductor activity in response to varying ventilatory resistance. Trans Am Acad
Ophthalmol Otolaryngol 1973; 77: 40310.
5. Ceriana P, Carlucci A, Navalesi P et al.
Weaning from tracheotomy in long-term
mechanically ventilated patients: feasibility
of a decisional flowchart and clinical outcome. Intensive Care Med 2003; 29: 8458.
6. Hess D R. Facilitating Speech in the Patient
With a Tracheostomy. Respir Care 2005; 50:
51925.
7. Bach JR, Goncalves M. Ventilator Weaning
by Lung Expansion and Decannulation. Am
J Phys Med Rehabil 2004; 83: 5608.
8. Christopher KL. Tracheostomy Decannulation. Respir Care 2005; 50: 53841.
9. Baskin JZ, Panagopoulos G, Parks C et al.
Clinical outcomes for the elderly patient
receiving a tracheotomy. Head Neck. 2004;
26: 71.

| 4 | 2007

www.sia-r.ru

55

www.sia-r.ru

| 4 | 2007

56
4

| 4 | 2007

www.sia-r.ru

www.sia-r.ru

57

| 4 | 2007

58

10 -

11 -

12

| 4 | 2007

www.sia-r.ru

59

13

14

15

www.sia-r.ru

| 4 | 2007

60

16

17 , ()
()

18

| 4 | 2007

www.sia-r.ru

61

19

20

21

www.sia-r.ru

| 4 | 2007

62

22 ,

S. epidermidis

S. aureus

C. albicans

23

24

| 4 | 2007

www.sia-r.ru

63

25

26

27

www.sia-r.ru

| 4 | 2007

64

28

29 (%)

30 ,

| 4 | 2007

www.sia-r.ru

, ,





-

- . ..
()
()



-

3-


, 2124 2008 .
1.
2.
3.
4. - , -
5. :
6. : ,
7.
8.
. .. (, , . 135)
Times New Roman 12 1,0.
4 ( 2 , 3 ,
1 ). , , , . .
,
phlebo-union@mtu-net.ru
15 2007 .

:
, -. , . +7-495-236-02-49, e-mail: phlebounion@mtu-net.ru
, . +7-495-237-42-62, e-mail: phlebo-union@bk.ru

www.phlebo-union.ru

www.sia-r.ru

| 4 | 2007

65

66

,

:
;
2
, Times New Roman, 14;
;
;
: , , , , , ( );
, ;
, ;
.
, :
, ;
;
;
.
:
1. .
2. .
3. ,
.
4. , , ,
, .

(
250 ). , 3 10 , .

, ,
, .

, .

,
, .

, ,
,
. ,

| 4 | 2007

,
.
, Index Medicus
(http://www.nlm.nih.gov/).

.
.
().
.

.
()

JPEG.
.

, ,
(, , ) .
,

.

( SI).

(). ,
,
.


, , .
, . :
1.
.
2. , .
3. ,
, , , ,
.

, , 1975 . 1983 . , , .

www.sia-r.ru